263 related articles for article (PubMed ID: 31948939)
1. Towards Multidrug Adaptive Therapy.
West J; You L; Zhang J; Gatenby RA; Brown JS; Newton PK; Anderson ARA
Cancer Res; 2020 Apr; 80(7):1578-1589. PubMed ID: 31948939
[TBL] [Abstract][Full Text] [Related]
2. Adaptive therapy.
Gatenby RA; Silva AS; Gillies RJ; Frieden BR
Cancer Res; 2009 Jun; 69(11):4894-903. PubMed ID: 19487300
[TBL] [Abstract][Full Text] [Related]
3. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
Yeang CH; Beckman RA
Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary analysis of replicator dynamics about anti-cancer combination therapy.
Zhao R; Lai X
Math Biosci Eng; 2023 Jan; 20(1):656-682. PubMed ID: 36650783
[TBL] [Abstract][Full Text] [Related]
5. Precision Therapy in RAS Mutant Colorectal Cancer.
Dienstmann R; Connor K; Byrne AT;
Gastroenterology; 2020 Mar; 158(4):806-811. PubMed ID: 31972237
[No Abstract] [Full Text] [Related]
6. The multi-factorial nature of clinical multidrug resistance in cancer.
Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
[TBL] [Abstract][Full Text] [Related]
7. Cancer therapy: an evolved approach.
Willyard C
Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079
[No Abstract] [Full Text] [Related]
8. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer.
Hu CM; Zhang L
Biochem Pharmacol; 2012 Apr; 83(8):1104-11. PubMed ID: 22285912
[TBL] [Abstract][Full Text] [Related]
9. Optimal Therapy Scheduling Based on a Pair of Collaterally Sensitive Drugs.
Yoon N; Vander Velde R; Marusyk A; Scott JG
Bull Math Biol; 2018 Jul; 80(7):1776-1809. PubMed ID: 29736596
[TBL] [Abstract][Full Text] [Related]
10. Role of synergy and antagonism in designing multidrug adaptive chemotherapy schedules.
Ma Y; Newton PK
Phys Rev E; 2021 Mar; 103(3-1):032408. PubMed ID: 33862722
[TBL] [Abstract][Full Text] [Related]
11. Searching for Goldilocks: How Evolution and Ecology Can Help Uncover More Effective Patient-Specific Chemotherapies.
Park DS; Luddy KA; Robertson-Tessi M; O'Farrelly C; Gatenby RA; Anderson ARA
Cancer Res; 2020 Dec; 80(23):5147-5154. PubMed ID: 32934022
[TBL] [Abstract][Full Text] [Related]
12. Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies.
Gallaher JA; Enriquez-Navas PM; Luddy KA; Gatenby RA; Anderson ARA
Cancer Res; 2018 Apr; 78(8):2127-2139. PubMed ID: 29382708
[TBL] [Abstract][Full Text] [Related]
13. Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
Benzekry S; Pasquier E; Barbolosi D; Lacarelle B; Barlési F; André N; Ciccolini J
Semin Cancer Biol; 2015 Dec; 35():53-61. PubMed ID: 26361213
[TBL] [Abstract][Full Text] [Related]
14. The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolution.
Chen A; Yang J; Hu S; Wang QF
Sci China Life Sci; 2015 Dec; 58(12):1302-5. PubMed ID: 26588914
[No Abstract] [Full Text] [Related]
15. Stochastic modeling of drug resistance in cancer.
Komarova N
J Theor Biol; 2006 Apr; 239(3):351-66. PubMed ID: 16194548
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Drug Combinations, How Far We can Go Through?
Lu DY; Chen EH; Wu HY; Lu TR; Xu B; Ding J
Anticancer Agents Med Chem; 2017; 17(1):21-28. PubMed ID: 27039923
[TBL] [Abstract][Full Text] [Related]
17. Engineering Multidimensional Evolutionary Forces to Combat Cancer.
McCoach CE; Bivona TG
Cancer Discov; 2019 May; 9(5):587-604. PubMed ID: 30992280
[TBL] [Abstract][Full Text] [Related]
18. Capitalizing on competition: An evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment.
West J; Ma Y; Newton PK
J Theor Biol; 2018 Oct; 455():249-260. PubMed ID: 30048718
[TBL] [Abstract][Full Text] [Related]
19. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
20. Calculated resistance in cancer.
Sawyers CL
Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
[No Abstract] [Full Text] [Related]
[Next] [New Search]
